Technological Advancements to Boost Respiratory Disease Testing Market by 2024 - PowerPoint PPT Presentation

Loading...

PPT – Technological Advancements to Boost Respiratory Disease Testing Market by 2024 PowerPoint presentation | free to download - id: 876eda-MWRlY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Technological Advancements to Boost Respiratory Disease Testing Market by 2024

Description:

Respiratory Disease Testing Market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period. – PowerPoint PPT presentation

Number of Views:0

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Technological Advancements to Boost Respiratory Disease Testing Market by 2024


1
Cancer Profiling Market size is projected to
experience significant growth from 2017 to 2024.
Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2
Regional Analysis of Cancer Profiling Market
  • Rising prevalence of cancer worldwide and huge
    funding available for oncology research are the
    major factors driving global cancer profiling
    market growth. In addition, the increase in the
    utility of biomarkers and high demand for the
    point-of-care diagnostic testing will fuel the
    demand for the oncology profiling over the coming
    years.
  • The obtainability of custom-made medical
    treatment that will suit specific physiognomies,
    preferences, and requirements of patients coupled
    with intensifying compliance for the tumor
    profiling in developing economies should propel
    the industry.
  • According to the International Agency for
    Research on Cancer (IARC), the global burden for
    cancer by 2030, is projected to reach 21.7
    million new cases. As per American Cancer
    Society, by end of 2017 there will be 1,688,780
    new cases of cancer identified in the U.S. High
    capital investment and rising demand for the
    personalized medicine are other major factors
    boosting the industry size.
  • The forthcoming disease burden will possibly
    remain higher since adoption of western
    lifestyle, including inactiveness, poor diet,
    smoking, etc. High associated cost with profiling
    and dearth of trained specialists can limit the
    business growth during the forecast years.

3
  • Personalized medicine reduces possibility of
    adverse side effects and additional healthcare
    expenses. Moreover, capability to take health
    decisions regarding disease prediction and
    prevention as well as prior disease intervention
    is being possible because of personalized
    medicines.
  • Genomics will witness lucrative growth due to its
    wide-ranging clinical, diagnostics and research
    applications.
  • Increasing government funding and grants along
    with investments are the determinants to fuel the
    cancer profiling market growth during the
    forecast timeframe. Moreover, the increased
    adoption of the genomics in RD and research
    studies offers immense growth opportunities.
  • Next-generation sequencing (NGS) accounted for
    largest share in cancer profiling technology in
    2016. Associated advantages include recognition
    of transmutation, advanced genome with reduction
    in cost, high speed and sensitivity.

4
Competitive Market Share of Cancer Profiling
Market
  • Several initiatives undertaken to prevent the
    breast and colorectal cancers should fuel U.S.
    cancer profiling market growth. For instance, the
    Molecular Profiling Breast Cancer (MPBC) is
    altering medical training and improving
    management of breast oncology in the U.S.
    Moreover, the colorectal cancer is the second
    major cause of death in U.S. and there is
    necessity to profile and detect tumors at initial
    stages in order to provide appropriate treatment.
  • China will foresee lucrative growth over the
    coming years due to rising demand for the better
    healthcare service coupled with increasing
    occurrence of tumor. Furthermore, growing number
    of the contract research organizations (CROs) and
    major international players focusing on
    developing economies to expand their business
    will drive regional share.

5

Browse Full Market Research Report On Cancer
Profiling Market _at_ http//bit.ly/2uuKfIR
Request for an in-depth table of contents for
this report _at_ http//bit.ly/2tPdW4E
6
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com